Wegovy Injection vs. Tablet: What Is the Difference? (2026 UK Guide)
In this guide
Quick answer: Wegovy injection and Wegovy tablet both contain the same active ingredient, semaglutide, and produce comparable weight loss. The injection is taken once a week with no food restrictions; the tablet is taken once daily on an empty stomach with a strict 30-minute fasting window. The tablet was approved by the MHRA on 11 June 2026 as the UK's first oral GLP-1 weight-loss medicine, but is not yet commercially available.
Wegovy Injection vs. Wegovy Tablet: Comparison Table
| Feature | Wegovy Weekly Injection | Wegovy Daily Tablet |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Dosing frequency | Once a week | Once a day |
| How it's taken | Subcutaneous injection | Swallowed whole as a tablet |
| Maintenance dose | 2.4 mg | 25 mg |
| Absorption rate | ~89% | ~1% (requires SNAC absorption enhancer) |
| Storage | Refrigerate before first use | Room temperature |
| Eating restrictions | None — take any time, with or without food | Strict: empty stomach, 30 min fast after dosing |
| Water with dose | Not applicable | Max 120 ml (4 oz) plain water |
| UK regulatory status (June 2026) | Available via NHS specialist services and private prescribers | MHRA-approved (11 June 2026); not yet commercially available |
Why Is the Tablet Dose So Much Higher Than the Injection?
Both forms reach the bloodstream and work identically once absorbed — the difference is how much survives the journey there.
| Injection | Tablet | |
|---|---|---|
| Route | Injected under the skin (subcutaneous) | Swallowed, must pass through stomach acid |
| Absorption | ~89% of the dose | ~1% of the dose |
| Why | Absorbed steadily from fat tissue | Stomach acid breaks down most of the drug before it can cross the stomach lining |
| Solution | N/A | SNAC (salcaprozate sodium) temporarily neutralises acid around the tablet, letting a small fraction of semaglutide cross the stomach lining |
Because so little of the oral dose survives digestion even with SNAC, the tablet needs a 25 mg dose to deliver an equivalent effect to the 2.4 mg weekly injection.
Wegovy Tablet Dosing Schedule
The MHRA-approved schedule follows a four-step escalation over roughly three months:
| Step | Dose | Typical duration |
|---|---|---|
| 1 | 1.5 mg daily | At least 1 month |
| 2 | 4 mg daily | At least 1 month |
| 3 | 9 mg daily | At least 1 month |
| 4 (maintenance) | 25 mg daily | Ongoing |
A prescriber may extend any step if side effects need more time to settle.
How to Take the Wegovy Tablet (Step-by-Step)
| Step | Instruction | Why it matters |
|---|---|---|
| 1 | Take first thing in the morning, after an overnight fast | Absorption only works when the stomach is empty |
| 2 | Swallow whole with no more than 120 ml (4 oz) plain water | More water dilutes the SNAC absorption enhancer |
| 3 | Do not crush, split, or chew the tablet | Breaks the absorption mechanism, making the dose unpredictable |
| 4 | Wait at least 30 minutes before food, drink, or other oral medicines | Gives semaglutide time to cross the stomach lining before digestion resumes |
| 5 | Waiting longer (up to 2 hours) further improves absorption | Studies show extending the gap increases the amount absorbed |
| 6 | If a dose is missed, skip it — do not double up | Avoids inconsistent dosing |
How Effective Is the Tablet Compared to the Injection?
| Trial | Medication | Duration | Average weight loss (vs. placebo) |
|---|---|---|---|
| STEP 1 (NEJM, 2021) | Weekly 2.4 mg injection | 68 weeks | 14.9% (vs ~2.4% placebo) |
| OASIS 4 (NEJM, 2025) — all participants | Daily 25 mg tablet | 64 weeks | 13.6% (vs 2.2% placebo) |
| OASIS 4 — participants who followed the routine consistently | Daily 25 mg tablet | 64 weeks | 16.6% (vs 2.7% placebo) |
Key takeaway: When the daily routine is followed correctly, the tablet's results are broadly comparable to the injection. STEP 1 and OASIS 4 were separate trials in different populations, so this is an indirect comparison rather than a head-to-head study — but the overall efficacy signal is consistent across both.
Side Effects: Injection vs. Tablet
| Side effect | Injection | Tablet |
|---|---|---|
| Nausea | Common | Common (slightly higher at peak doses) |
| Indigestion / acid reflux | Common | Common |
| Diarrhoea / constipation | Common | Common |
| Injection-site reactions (redness, bruising) | Possible | Not applicable |
Both forms share a similar overall safety profile, as semaglutide is the same active ingredient in each.
Which One Is Right for You?
| You might prefer the injection if you… | You might prefer the tablet if you… |
|---|---|
| Dislike daily routines and prefer a "set and forget" weekly dose | Dislike needles |
| Don't want to worry about fasting windows | Travel frequently and don't want to manage refrigeration |
| Want to take your dose at any time of day | Have a consistent, disciplined morning routine |
Switching from the Injection to the Tablet
If you're considering switching from the weekly injection to the daily tablet, this should be done under medical supervision. Because semaglutide has a long half-life (roughly a week), your prescriber will advise on the right timing to avoid overlapping doses — this is typically managed by allowing the previous injection to clear before starting the tablet at an appropriate introductory dose. Always speak to your prescribing clinician before changing your regimen; do not switch formulations on your own.
Is the Wegovy Tablet Available in the UK?
| Question | Answer |
|---|---|
| Has it been approved? | Yes — MHRA approval granted 11 June 2026 |
| Is it available to buy now? | Not yet — approval does not equal commercial availability |
| Will it be on the NHS? | Undecided — requires a separate NICE cost-effectiveness review |
| Who is it licensed for? | Adults with BMI ≥30, or BMI 27–30 with at least one weight-related health condition |
This guide is for informational purposes only and is not a substitute for medical advice. Wegovy is a prescription-only medicine. Speak to a healthcare professional or complete an online consultation to check your eligibility.
Sources: MHRA (June 2026 licensing decision); Wharton et al., "Efficacy and safety of oral semaglutide 25 mg," NEJM; Wilding et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," NEJM 384:989-1002 (2021); Buckley et al., "Transcellular stomach absorption of a derivatized GLP-1 receptor agonist," Science Translational Medicine 10(467) (2018).
FAQs
Is the Wegovy tablet as effective as the injection?
Clinical trial data suggests broadly comparable weight loss when the tablet's strict morning routine is followed consistently, though the two medicines have not been tested head-to-head in the same trial.
Why is the Wegovy tablet dose (25 mg) so much higher than the injection (2.4 mg)?
Because only around 1% of an oral dose is absorbed (versus ~89% for an injection), a much larger oral dose is needed to deliver an equivalent amount of semaglutide into the bloodstream.
Do I need to fast before taking the Wegovy tablet?
Yes — take it first thing in the morning on an empty stomach, with no more than 120 ml of water, and wait at least 30 minutes before eating, drinking, or taking other oral medicines.
Can I switch from the Wegovy injection to the tablet?
Only under medical supervision. Your prescriber will determine the right timing and starting dose based on your current treatment.
Is the Wegovy pill available in UK pharmacies now?
It was MHRA-approved on 11 June 2026 but has not yet launched commercially. NHS availability depends on a future NICE review.
Published 15th June 2026 by
Allan Green
Registered Pharmacist & Head of E-commerce
Allan has been a Registered Pharmacist for 25+ years
He specializes in Ecommerce and Over the Counter medicines.
He is a Registered Pharmacist, who studied at University of Bradford.
He has been with Weldricks since 2006, starting as a branch manager before moving into area management and deputy superintendent roles.
His current responsibilities include web development, marketing, content, customer service and web operations teams.
Related Products
-
Wegovy Flextouch 0.25MG (SEMAGLUTIDE) pack of 1 £98.50 -
Wegovy Flextouch 0.5MG (SEMAGLUTIDE) Pack of 1 £119.00 -
Wegovy Flextouch 1.0mg (SEMAGLUTIDE) pack of 1 £148.00 -
Wegovy Flextouch 2.4MG (SEMAGLUTIDE) pack of 1 £198.00 -
Wegovy Flextouch 1.7MG (SEMAGLUTIDE) pack of 1 £178.00 -
Mounjaro Kwikpen 2.5MG/0.6ML (TIRZEPATIDE 2.5MG/0.6ML) £168.00 -
Mounjaro Kwikpen 5MG/0.6ML (TIRZEPATIDE 5MG/0.6ML) £198.00 -
Mounjaro Kwikpen 12.5MG/0.6ML (TIRZEPATIDE 12.5MG/0.6ML) £288.00 -
Mounjaro Kwikpen 7.5MG/0.6ML (TIRZEPATIDE 7.5MG/0.6ML) £248.00 -
Mounjaro Kwikpen 15MG/0.6ML (TIRZEPATIDE 15MG/0.6ML) £298.00 -
Mounjaro Kwikpen 10MG/0.6ML (TIRZEPATIDE 10MG/0.6ML) £278.00